Latest Leverage News

Capricorn Metals has fully repaid its remaining $50 million corporate debt ahead of schedule, positioning itself as debt and gold hedging free with strong cash reserves to back growth projects.

Aerometrex has renewed and extended its multi-million dollar agreement with Landchecker, significantly increasing its annual recurring revenue through the MetroMap platform.

Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.

Epsilon Healthcare and its subsidiaries have officially exited voluntary administration and Deeds of Company Arrangement, marking a pivotal recovery milestone supported by significant personal commitments from the new board. The company now shifts focus to strategic growth and rebuilding trust.

Blackstone Minerals has completed its acquisition of IDM International, issuing over 692 million shares and 83 million options, significantly expanding its copper-gold portfolio with the Mankayan project in the Philippines.

Alliance Aviation Services has entered a $32.5 million deal to sell the majority of its Embraer E190 spare parts inventory to AVIAN Management, marking a strategic partnership that enhances fleet support across the Asia-Pacific region.

Alvo Minerals has successfully closed its retail entitlement offer, raising $810,985 and bringing total proceeds from its recent capital raise to $1.56 million. The funds will support ongoing exploration at its Palma Cu/Zn Project and other mineral ventures in Brazil.

Koonenberry Gold’s joint venture with Newmont has delivered promising air core drilling results at the Junee Project, expanding known gold and copper mineralisation zones, while Fairholme JV results highlight porphyry system potential despite no significant assays.

Coventry Group Limited has appointed Nik Alpert as Acting Group CEO, while announcing the retirement of CFO Rod Jackson and the upcoming appointment of Patrick Maloney as his successor.

PYC Therapeutics has announced promising pre-clinical results for its RNA-based drug candidate PYC-002, targeting the genetic root of Phelan-McDermid Syndrome, with clinical trials expected to begin in 2026.

Following its merger with IDM International, Blackstone Minerals announces key board and management changes to spearhead development of the Mankayan Copper-Gold Project in the Philippines.

ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.